Selina Chen-Kiang

Professor of Pathology and Laboratory Medicine

Weill Cornell Medicine · New York, United States

About

Pioneer in understanding cell cycle dysregulation in MCL. Her work on cyclin D1 and CDK4/6 has been foundational to MCL biology and therapeutic development.

Specialties

Cell cycle biologyCDK4/6MCL biology

Publications (3)

MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma.

Blood advances · Feb 24, 2026

Leveraging BRG1 Driven Ferroptosis Resistance to Overcome Treatment Resistance.

bioRxiv : the preprint server for biology · Sep 5, 2025

Resistance to PRMT5-targeted therapy in mantle cell lymphoma.

Blood advances · Jan 9, 2024

Profile

https://weillcornell.org/sckiang